Fibulin-1 is a novel biomarker and high concentrations have primarily been reported in patients with aortic stenosis and DM compared to a level of 5.6 (4.1–8.4) μg/mL reported in healthy men [11, 20, 21]. Here, FBLN1 is linked to aortic stenosis.